Fundz

ImmuneBridge Promotes Dr. Nina Horowitz to CEO and Appoints Dr. Rui Tostoes as Chief Technology Officer

PRIVATEMar 24, 2026

Position

Chief Technology Officer

Company

ImmuneBridge

Rui Tostoes
San FranciscoBiotechnology

Description

ImmuneBridge has announced the promotion of Dr. Nina Horowitz to CEO, previously serving as the Chief Scientific Officer. Alongside this, Dr

Quick answer

ImmuneBridge Promotes Dr. Nina Horowitz to CEO and Appoints Dr. Rui Tostoes as Chief Technology Officer (March 24, 2026). ImmuneBridge is based in San Francisco, California, United States.

Who is the new Chief Technology Officer at ImmuneBridge?
ImmuneBridge named Rui Tostoes Chief Technology Officer, announced March 24, 2026.
What did ImmuneBridge announce on March 24, 2026?
ImmuneBridge has announced the promotion of Dr. Nina Horowitz to CEO, previously serving as the Chief Scientific Officer.
What does ImmuneBridge do?
ImmuneBridge is developing allogeneic immunotherapies for cancer.
Where is ImmuneBridge based?
ImmuneBridge is based in San Francisco, California, United States.
Which similar companies made leadership changes around the same time?
Pediatrix Medical Group (March 24, 2026), Solventum (March 24, 2026), Onconetix (March 25, 2026) and Granules India (March 25, 2026) also announced leadership changes within 45 days of ImmuneBridge.

Source: Fundz verified event record.

Other recent leadership changes in Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at ImmuneBridge, and when

A new leader at ImmuneBridge brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day ImmuneBridge raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at ImmuneBridge, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at ImmuneBridge. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

ImmuneBridge

Location

2122 BRYANT ST

San Francisco, California, United States

About

ImmuneBridge is developing allogeneic immunotherapies for cancer. Our core technology drives the expansion of cord blood derived immune stem cells and establishes a novel, flexible, consistent and abundant cellular source for immunotherapies. We are currently pursuing natural killer cell products for hematological malignancies. Next we will use the unique advantages of our cellular source to tackle solid tumors.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment ImmuneBridge changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Nina
Likely contact at this company
••••••••@••••••••

See Nina's verified email →

Miguel
Senior decision-maker at this company
••••••••@••••••••

See Miguel's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for ImmuneBridge's next move

Learn about Strategic plan

ImmuneBridge changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.